ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $237,113 | -15.3% | 24,048 | -6.9% | 0.00% | 0.0% |
| Q4 2020 | $279,932 | +5.2% | 25,824 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $265,987 | -43.4% | 25,824 | +14.7% | 0.01% | -37.5% |
| Q2 2020 | $470,113 | +141.9% | 22,515 | +13.2% | 0.01% | +100.0% |
| Q1 2020 | $194,325 | +14.5% | 19,890 | +35.0% | 0.00% | +33.3% |
| Q4 2019 | $169,747 | +50.8% | 14,735 | -28.7% | 0.00% | +50.0% |
| Q3 2019 | $112,553 | -54.2% | 20,652 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $245,552 | +126.9% | 20,652 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $108,216 | -10.6% | 20,652 | +3.2% | 0.00% | 0.0% |
| Q3 2018 | $121,091 | -99.9% | 20,015 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $106,080,000 | – | 20,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |